Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET -Rearranged Lung Cancers

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.07.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Miliary Brain Metastases in a Patient With ROS1-Rearranged Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Association of Genetic and Immuno-Characteristics With Clinical Outcomes in Patients With RET-rearranged Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

P081 Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy

Cancer
Cancer ResearchOncology
2018English

RET-Rearranged Lung Adenocarcinomas With Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

The Activity, Safety, and Evolving Role of Brigatinib in Patients With ALK-rearranged Non-Small Cell Lung Cancers

OncoTargets and Therapy
OncologyPharmacology
2017English

Efficacy and Safety of Icotinib in Patients With Brain Metastases From Lung Adenocarcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

P071 Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy